Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enliven Therapeutics (ELVN) Depreciation and Depletion (2019 - 2026)

Enliven Therapeutics has reported Depreciation and Depletion over the past 8 years, most recently at $14000.0 for Q1 2026.

  • Quarterly results put Depreciation and Depletion at $14000.0 for Q1 2026, down 81.08% from a year ago — trailing twelve months through Mar 2026 was $203000.0 (down 34.94% YoY), and the annual figure for FY2025 was $263000.0, down 17.03%.
  • Depreciation and Depletion reached $14000.0 in Q1 2026 per ELVN's latest filing, down from $46000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $400000.0 in Q2 2022 and bottomed at $14000.0 in Q1 2026.
  • Median Depreciation and Depletion over the past 5 years was $74000.0 (2023), compared with a mean of $85529.4.
  • The largest annual shift saw Depreciation and Depletion skyrocketed 1500.0% in 2022 before it tumbled 81.5% in 2023.
  • Over 5 years, Depreciation and Depletion stood at $64000.0 in 2022, then grew by 21.88% to $78000.0 in 2023, then grew by 2.56% to $80000.0 in 2024, then crashed by 42.5% to $46000.0 in 2025, then crashed by 69.57% to $14000.0 in 2026.
  • Business Quant data shows Depreciation and Depletion for ELVN at $14000.0 in Q1 2026, $46000.0 in Q4 2025, and $62000.0 in Q3 2025.